Jeff Bezos hunting for a massive $130 billion private valuation for Blue Origin exposes the extreme relative discount of Rocket Lab's public shares.
Long Rocket Lab (RKLB) on dips following its $8B acquisition of Iridium, which transforms it into a fully integrated space business with analyst price targets up to $150.00.
Rocket Lab is swallowing Iridium for $8 billion to fuse rocket launches with satellite networks and directly battle SpaceX as an integrated space giant.
Sequoia's all-hands LA space hardware tour signals fresh top-tier VC conviction in new-space manufacturing, and RKLB is the most liquid public proxy
Space names like RKLB are down 40% in a month on macro fears — the selloff looks overshot as the underlying buildout thesis is unchanged
RKLB joins Nasdaq-100 Monday, forcing passive fund buying before the open
Space/quantum/misc-tech bubble stocks are newly shorted as overextended narratives; Rocket Lab is the cleanest space-bubble proxy
US-China orbital compute race requires satellite platform builders; Rocket Lab is the only end-to-end space company with launch, spacecraft, and components under one roof.
Short space stocks into the SpaceX IPO; the pre-IPO pump is a fade that already unwound hard
Satellite operators want launch competition, so they back Rocket Lab and Blue Origin, which is bullish for launch names.
Launch cadence and orbital infrastructure become the binding constraint, so own the launch layer
Rocket Lab is far and away the best space stock to ride the SpaceX IPO tailwind
Rocket Lab is building the Neutron medium-lift rocket to break SpaceX's launch monopoly and capture a slice of the $7.4 billion alternative launch market.
A SpaceX IPO validates space as a public category, and listed space primes re-rate to the new benchmark.